HIV medication is not automatically free in the United States, but multiple overlapping programs make it possible for most people to get their drugs at no cost or very low cost, regardless of income or insurance status. The retail price of a common one-pill regimen like Biktarvy runs about $4,216 per month, so these programs matter enormously. Between federal assistance, state programs, Medicaid, and drug manufacturer programs, very few people need to pay full price.
The Ryan White Program and ADAP
The largest safety net for HIV medication is the AIDS Drug Assistance Program, or ADAP, which operates under the federal Ryan White HIV/AIDS Program. ADAP received roughly $900 million in federal funding for fiscal year 2025. Every U.S. state and territory runs its own version of the program, and each one covers at least one drug from every class of HIV antiretroviral medication on the market. All drugs purchased through the program must be FDA-approved.
Eligibility is based on income, measured as a percentage of the federal poverty level (FPL). In 2023, the FPL for a single-person household was $14,580. Most states set their ADAP income cutoff at either 400% or 500% of FPL. That means in a state using 500% FPL, a single person earning up to about $72,900 could qualify for free HIV medication through ADAP. States like California, Texas, Colorado, Pennsylvania, and Massachusetts all use the 500% threshold. Others, including Florida, Georgia, Illinois, and Washington, set the bar at 400% FPL. A handful of states, including New York, New Mexico, and Wisconsin, use a lower 300% FPL cutoff, though New York supplements this with additional uninsured care programs.
You must live in the state where you’re applying. Each state also decides which specific drugs appear on its formulary, so the exact medications available vary by location. Your prescribing provider or pharmacy can typically help with the application.
Medicaid Coverage
If you qualify for Medicaid, your HIV medications are covered. State Medicaid programs are required by federal law to cover all FDA-approved medications from manufacturers that have entered into federal rebate agreements, which includes all antiretrovirals currently on the market. Copays under Medicaid are minimal or nonexistent depending on your state and income level. In states that expanded Medicaid under the Affordable Care Act, single adults earning up to 138% of the federal poverty level generally qualify.
Drug Manufacturer Assistance Programs
The two biggest HIV drug manufacturers, Gilead Sciences and ViiV Healthcare, both run patient assistance programs (PAPs) that provide medication for free to people who qualify. Both companies set their income cap at 500% of the federal poverty level. These programs are designed for people who are uninsured or underinsured and can’t access their medication through other channels.
The application process for both companies starts with an online eligibility check. ViiV also connects applicants with an access coordinator. Your doctor’s office or pharmacy often needs to complete part of the paperwork. Once enrolled, you’re covered for 12 months and must re-enroll annually. If you take medications from different manufacturers, you need to apply to each company separately.
Copay Assistance for Insured Patients
If you have private insurance but face high copays or deductibles, both Gilead and ViiV offer copay assistance programs that cap your annual out-of-pocket costs. These work differently from the free medication programs: the company pays a set dollar amount toward your copay each year. For Gilead’s Biktarvy, that cap is $7,200 per year. For ViiV’s Dovato, it’s $6,250 per year. Injectable treatments like Cabenuva carry a higher cap of $13,000 per year. Once you hit the annual dollar limit, you become responsible for any remaining copay costs, so it’s worth checking the specific cap for your medication.
Programs for the Uninsured
If you have no insurance at all, you’re not shut out. ADAP specifically serves uninsured individuals, and the manufacturer patient assistance programs are largely designed for this group. Some states go further with comprehensive uninsured care programs. New York, for example, offers free primary care, home care, and insurance premium assistance alongside ADAP for residents under 500% FPL. Many community health centers and HIV clinics across the country also provide care on a sliding-fee scale regardless of insurance or immigration status.
The Ryan White Program does not require U.S. citizenship for eligibility. Residency in the state is the key requirement. This means undocumented individuals can access ADAP in many states, though specific policies vary by location. Federally qualified health centers, which exist in every state, are another important access point because they serve patients regardless of ability to pay or documentation status.
PrEP (Prevention) Is Also Available for Free
If you’re searching about HIV medication costs because you want to prevent HIV rather than treat it, a separate federal program called Ready, Set, PrEP provides pre-exposure prophylaxis medication at no cost to qualifying individuals. The program is aimed at people who are uninsured and at risk for HIV. It grew out of a 2019 agreement in which Gilead Sciences committed to donating PrEP medication for up to 200,000 people per year for up to 11 years. Several state programs, including New York’s PrEP Assistance Program, also cover the lab work and clinical visits that go along with taking PrEP.
How to Find the Right Program
The quickest starting point is to talk to your HIV care provider or clinic, since they deal with these programs daily and can steer you to the right one. If you’re uninsured and under 500% FPL, your state’s ADAP program is typically the first option to pursue. If you have private insurance with high out-of-pocket costs, the copay assistance card from your medication’s manufacturer is usually the fastest relief. If you’re on Medicaid, your drugs are already covered.
Multiple programs can sometimes be layered together. For instance, ADAP can help pay insurance premiums in some states, and copay cards can reduce whatever costs remain after insurance. The goal across all these programs is the same: keeping cost from becoming a barrier to staying on treatment, since consistent medication use is what keeps HIV suppressed and prevents transmission.